214 results on '"PASSERINI, LAURA"'
Search Results
2. A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB
3. Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential
4. IL-10-producing regulatory cells impact on celiac disease evolution
5. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients
6. Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases
7. Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3
8. IPEX Syndrome: Clinical Profile, Biological Features, and Current Treatment
9. Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report
10. Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases
11. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells
12. Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
13. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells
14. Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses
15. Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
16. IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis
17. Defective regulatory and effector T cell functions in patients with FOXP3 mutations
18. IPEX Syndrome: Clinical Profile, Biological Features, and Current Treatment
19. Clinical Heterogenity of Inherited Multiple Autoimmunity: Is it only “IPEX-Like”?
20. Induction of Antigen-Specific Tolerance in T Cell Mediated Diseases
21. Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo
22. Isolation, Expansion, and Characterization of Human Natural and Adaptive Regulatory T Cells
23. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25− effector T cells
24. QSARs for Individual Classes of Chemical Mutagens and Carcinogens
25. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
26. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs
27. Combined DOCK8 and CLEC7A mutations causing immunodeficiency in 3 brothers with diarrhea, eczema, and infections
28. Analysis of SjTREC Levels in Thymus from MG Patients and Normal Children
29. Expression of Transforming Growth Factor-β1 in Thymus of Myasthenia Gravis Patients: Correlation with Pathological Abnormalities
30. Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability
31. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: Inconsistent correlation between forkhead box protein 3 expression and disease severity
32. Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease
33. Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis
34. Corrigendum: Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses
35. Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses
36. HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
37. Forkhead-Box-P3 Gene Transfer in Human CD4+ T Conventional Cells for the Generation of Stable and Efficient Regulatory T Cells, Suitable for Immune Modulatory Therapy
38. HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
39. 681. HIV-1 Mediated Insertional Activation of STAT5B and BACH2 Promotes the Formation of a Viral Reservoir in T Regulatory Cells
40. Clinical Outlook for Type-1 and FOXP3+ T Regulatory Cell-Based Therapy
41. Monitoring T-cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.
42. 26. HIV-1 Mediated Insertional Mutagenesis Increase the Persistence of Infected T Cells in Patients Under ART by Triggering Their Differentiation Into Long Lived T-Regulatory and T-Central Memory Cells
43. Human in vitro induced T regulatory cells and memory T cells share common demethylation of specific FOXP3 promoter region
44. Gene/Cell Therapy Approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome
45. The role of FOXP3 in regulatory and effector function of CD4⁺ T cells isolated from patients with FOXP3 mutations
46. Forkhead-Box-P3 Gene Transfer in Human CD4+ T Conventional Cells for the Generation of Stable and Efficient Regulatory T Cells, Suitable for Immune Modulatory Therapy.
47. Isolation, Expansion, and Characterization of Human Natural and Adaptive Regulatory T Cells
48. Forkhead box P3:The Peacekeeper of the Immune System
49. CD4 + T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer
50. Autoantibodies to Harmonin and Villin Are Diagnostic Markers in Children with IPEX Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.